Gregory Wujek
Keine laufenden Positionen mehr
Profil
Gregory Wujek served as Chief Executive Officer at Castle Creek Biosciences, Inc. from 2019 to 2019.
Prior to that, he was Director at Ceres Ventures, Inc. in 2010, Vice President-Sales at Savient Pharmaceuticals, Inc. from 2005 to 2006, Vice President-Sports Medicine at Zimmer Biomet Holdings, Inc. from 2013 to 2016, and Vice President-Business Development at Andrx Laboratories, Inc. from 2000 to 2005.
He also served as Chief Commercial Officer at Castle Creek Biosciences, Inc. from 2020 to 2021.
Wujek earned his undergraduate degree from Illinois State University in 1986.
Ehemalige bekannte Positionen von Gregory Wujek
| Unternehmen | Position | Ende |
|---|---|---|
Castle Creek Biosciences, Inc.
 Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Corporate Officer/Principal | 01.10.2021 |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Chief Executive Officer | 01.12.2019 |
| ZIMMER BIOMET HOLDINGS, INC. | Corporate Officer/Principal | 01.06.2016 |
| CERES VENTURES, INC. | President | 22.03.2010 |
| SAVIENT PHARMACEUTICALS INC | Sales & Marketing | 01.03.2006 |
Ausbildung von Gregory Wujek
| Illinois State University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ZIMMER BIOMET HOLDINGS, INC. | Health Technology |
| CERES VENTURES, INC. | Health Services |
| Private Unternehmen | 3 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
Andrx Laboratories, Inc.
 Andrx Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Andrx Laboratories, Inc. was a specialty pharmaceuticals company that was acquired by Watson Pharmaceuticals in November 2006. It engaged in the development and commercialization of controlled-release branded pharmaceuticals and generics. The company was founded in 1995 and was headquartered in Fort Lauderdale, FL. | Health Technology |
Castle Creek Biosciences, Inc.
Castle Creek Biosciences, Inc. BiotechnologyHealth Technology Castle Creek Biosciences, Inc. engages in the research and development of gene therapies for patients with rare and genetic diseases. It offers treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) and localized Scleroderma; and topical ointment for Epidermolysis Bullosa Simplex. The company was founded by Jeffrey S. Aronin in September 2018 and is headquartered in Exton, PA. | Health Technology |
